Home›Search›Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment

Dove Medical Press Ltd. · New Zealand · Est. 1971

ISSN1178-2021eISSN1178-2021

SJR Q2✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.947

H-Indexi

120

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.872

Total Worksi

4,580

Total Citationsi

116,694

2yr Mean Citednessi

2.31

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

General Information

Country / RegionNew Zealand

Primary LanguageEnglish

1st Year Published1971

FrequencyAnnual, 2009-

StatusActive (last: 2026)

Total Publications4,580

Publisher OrgDove Medical Press

OA Since2007

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~16 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Dove Medical Press Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1178-2021 / 1178-2021

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

335

8.3k

2019

325

9.4k

2020

351

5.8k

2021

271

3.5k

2022

249

2.5k

2023

228

1.1k

2024

217

433

2025

127

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Psychiatry and Mental HealthQ2

Biological PsychiatryQ3

Subject Classification

Web of Science Categories

Clinical NeurologyPsychiatry

Scopus Categories

Biological PsychiatryPsychiatry and Mental Health

Research Topics (OpenAlex)

Schizophrenia research and treatmentTreatment of Major DepressionTryptophan and brain disordersBipolar Disorder and TreatmentDementia and Cognitive Impairment ResearchAttention Deficit Hyperactivity DisorderAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesParkinson's Disease Mechanisms and TreatmentsAutism Spectrum Disorder ResearchEpilepsy research and treatment

Frequently asked questions about Neuropsychiatric Disease and Treatment

Is Neuropsychiatric Disease and Treatment a predatory journal?

PubScope has no integrity flags on record for Neuropsychiatric Disease and Treatment: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Neuropsychiatric Disease and Treatment?

Neuropsychiatric Disease and Treatment is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.31.

Is Neuropsychiatric Disease and Treatment indexed in Scopus and Web of Science?

Neuropsychiatric Disease and Treatment is indexed in Web of Science, Scopus, DOAJ.